Incidental Diagnosis of Pancreatic Cancer and Association with Improved Patient Outcomes: Assessing the Potential Clinical Use of Liquid Biopsy-Based Screening Tests
Approximately 10% of patients with PDAC are diagnosed incidentally. In resected PDAC, incidental diagnosis is independently associated with improved OS. Multianalyte screening tests perform equally well in asymptomatic and symptomatic patients. These findings further reinforce the need to develop screening tools that increase the rate of diagnosis at an asymptomatic stage and improve survival.
Authors
- Elliot K. Fishman (ORCID: https://orcid.org/0000-0002-2567-1658)
- Christopher L. Wolfgang (ORCID: https://orcid.org/0009-0000-5817-6146)
- Joseph R. Habib (ORCID: https://orcid.org/0000-0003-3445-2278)
- Jing He (ORCID: https://orcid.org/0000-0002-1954-2892)
- Ammar A. Javed (ORCID: https://orcid.org/0000-0002-5463-5250)
- John L. Cameron
- Ralph H. Hruban
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- NYU Langone Health (US)
Publication Details
- Journal
- Journal of the American College of Surgeons
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1097/xcs.0000000000001721
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00